First-in-Human trial tests engineered immune cells to fight tough liver cancer
NCT ID NCT06084884
Summary
This study is testing a new treatment called AZD5851, a type of CAR-T cell therapy, for adults with advanced or returning liver cancer (hepatocellular carcinoma) that has a specific marker called GPC3. The main goals are to find a safe dose and see if the treatment can shrink tumors. It is for people whose cancer has continued to grow despite trying at least one standard treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Phoenix, Arizona, 85054, United States
-
Research Site
Duarte, California, 91010, United States
-
Research Site
Orange, California, 92868, United States
-
Research Site
San Francisco, California, 94143, United States
-
Research Site
Washington D.C., District of Columbia, 20007, United States
-
Research Site
Jacksonville, Florida, 32224, United States
-
Research Site
Atlanta, Georgia, 30322, United States
-
Research Site
Westwood, Kansas, 66205, United States
-
Research Site
Rochester, Minnesota, 55905, United States
-
Research Site
Hackensack, New Jersey, 07601, United States
-
Research Site
New York, New York, 10065, United States
-
Research Site
Columbus, Ohio, 43210, United States
-
Research Site
Portland, Oregon, 97239, United States
-
Research Site
Philadelphia, Pennsylvania, 19104, United States
-
Research Site
Pittsburgh, Pennsylvania, 15237, United States
-
Research Site
Kashiwa, 227-8577, Japan
-
Research Site
Osakasayama-shi, 589-8511, Japan
-
Research Site
Seoul, 03080, South Korea
Conditions
Explore the condition pages connected to this study.